MICB and neoplasm: Studies have shown that tumor stem cells can reduce and evade from NK cells by downregulating the active ligand of NK cells, such as major histocompatibility I polypeptide related sequences A (MICA) and histocompatibility I polypeptide related sequences B (MICB), so as to escape from immune surveillance [33].